3 Standout Stocks Under $10 With 86% Upside Potential or More
As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.
Barchart ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from OCUL
Expert Ratings for Ocular Therapeutix
Over the past 3 months, 4 analysts have published their opinion on Ocular Therapeutix (NASDAQ:OCUL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Benzinga ·
Ocular Therapeutix's Return On Capital Employed Overview
Benzinga Pro data, Ocular Therapeutix (NASDAQ:OCUL) reported Q4 sales of $12.31 million. Earnings fell to a loss of $3.85 million, resulting in a 244.9% decrease from last quarter.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Places
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
